Pressurized Perfusion System for Obtaining Completely Acellular Pulmonary Valve Scaffolds for Tissue Engineering

1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016 Jan;102(1):75-85.10.1136/heartjnl-2014-30702026541169Search in Google Scholar

2. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012 Mar;105(3):146-52.10.1016/j.acvd.2012.01.00522520797Search in Google Scholar

3. Cullen MW, Cabalka AK, Alli OO, Pislaru SV, Sorajja P, Nkomo VT, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013 Jun;6(6):598-605.10.1016/j.jcin.2013.02.01023683739Search in Google Scholar

4. Schillinger W, Senges J. (TRAMI (Transcatheter Mitral Valve Interventions) register. The German mitral register). Herz. 2013 Aug;38(5):453-9.10.1007/s00059-013-3858-323797374Search in Google Scholar

5. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7.10.1007/s11606-012-2077-6344567622618581Search in Google Scholar

6. Friedewald VE, Bonow RO, Borer JS, Carabello BA, Kleine PP, Akins CW, et al. The Editor’s Roundtable: cardiac valve surgery. Am J Cardiol. 2007 May 1;99(9):1269-78.10.1016/j.amjcard.2007.02.04017478156Search in Google Scholar

7. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, et al. Engineering complex tissues. Tissue Eng. 2006 Dec;12(12):3307-39.10.1089/ten.2006.12.3307282121017518671Search in Google Scholar

8. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):60-1.10.1038/ncpcardio011216265355Search in Google Scholar

9. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009 Apr;137(4):881-6, 6e1-5.10.1016/j.jtcvs.2008.09.028Search in Google Scholar

10. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91.Search in Google Scholar

11. Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int. 2008 Feb;105(8):143-8.10.3238/arztebl.2008.0143269673819633780Search in Google Scholar

12. Langer R, Vacanti JP. Tissue engineering. Science. 1993 May 14;260(5110):920-6.10.1126/science.84935298493529Search in Google Scholar

13. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000 Nov 7;102(19 Suppl 3):III22-9.10.1161/01.CIR.102.suppl_3.III-22Search in Google Scholar

14. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996 Nov 1;94(9 Suppl):II164-8.Search in Google Scholar

15. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000 Nov 7;102(19 Suppl 3):Iii44-9.10.1161/01.CIR.102.suppl_3.III-44Search in Google Scholar

16. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995 Dec;60(6 Suppl):S513-6.10.1016/S0003-4975(21)01185-1Search in Google Scholar

17. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011 Aug 15;13:27-53.10.1146/annurev-bioeng-071910-12474321417722Search in Google Scholar

18. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003;12(6):659-66.10.3727/00000000310874713628866947Search in Google Scholar

19. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004 Nov;25(26):5735-42.10.1016/j.biomaterials.2004.01.06615147819Search in Google Scholar

20. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg. 2004 Jul;40(1):146-53.10.1016/j.jvs.2004.03.03315218475Search in Google Scholar

21. Kajbafzadeh AM, Javan-Farazmand N, Monajemzadeh M, Baghayee A. Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng Part C Methods. 2013 Aug;19(8):642-51.10.1089/ten.tec.2012.033423270591Search in Google Scholar

22. Nakayama KH, Lee CC, Batchelder CA, Tarantal AF. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One. 2013;8(5):e64134.10.1371/journal.pone.0064134366147723717553Search in Google Scholar

23. DeQuach JA, Yuan SH, Goldstein LS, Christman KL. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A. 2011 Nov;17(21-22):2583-92.10.1089/ten.tea.2010.0724320419721883047Search in Google Scholar

24. Sierad LN, Shaw EL, Bina A, Brazile B, Rierson N, Patnaik SS, et al. Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System. Tissue Eng Part C Methods. 2015 Dec;21(12):1284-96.10.1089/ten.tec.2015.0170Search in Google Scholar

25. Kerrison P, Steinke M. DAPI staining protocol.Search in Google Scholar

26. Inno-train Diagnostic GMBH. Manual DNA Extraction with magnetic beads. 2019 (cited 2019); Available from: https://www.inno-train.de/en/products/dna-isolation/bexs-12-ready-dna-kits/.Search in Google Scholar

27. Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg. 2006 Jul;30(1):28-32.10.1016/j.ejcts.2006.02.06916730181Search in Google Scholar

28. Freling HG, van Slooten YJ, van Melle JP, Ebels T, Hoendermis ES, Berger RM, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg. 2015 Mar;99(3):905-10.10.1016/j.athoracsur.2014.10.03425617228Search in Google Scholar

29. Schwedler G, Lindinger A, Lange PE, Sax U, Olchvary J, Peters B, et al. Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects. Clin Res Cardiol. 2011 Dec;100(12):1111-7.10.1007/s00392-011-0355-721909849Search in Google Scholar

30. Shebani SO, McGuirk S, Baghai M, Stickley J, De Giovanni JV, Bu’lock FA, et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg. 2006 Mar;29(3):397-405.10.1016/j.ejcts.2005.11.04016439155Search in Google Scholar

31. Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry datadagger. Eur J Cardiothorac Surg. 2019 Sep 1;56(3):503-910.1093/ejcts/ezz054673576330879050Search in Google Scholar

32. Arise Hannover. Welcome to Arise. 2019; Available from: http://arise-clinicaltrial.eu/home.html.Search in Google Scholar